Showing results (341-350 of 426) with videos related to
Sort By:
Pageof 43
Human Antibodies|December 24, 2010
Preparation and in vitro evaluation of 111In-CHX-A"-DTPA-labeled anti-VEGF monoclonal antibody bevacizumabSeyed Jalal Hosseinimehr, Anna Orlova, Vladimir TolmachevHuman Antibodies|September 5, 2009
Target therapy of cancer: implementation of monoclonal antibodies and nanobodiesJafar Majidi, Jaleh Barar, Behzad Baradaran, et al.Human Antibodies|January 1, 1997
Anti-tumor activity of monoclonal antibody CIBCNSH3 generated to the human EGF receptorM Udayachander, C J Dean, A N Meenakshi, et al.Human Antibodies|January 1, 1997
Humanization of a mouse antibody against human alpha-4 integrin: a potential therapeutic for the treatment of multiple sclerosisO J Léger, T A Yednock, L Tanner, et al.Human Antibodies|January 1, 1997
Incorporation of T cell counterparts in the fusion partners for generation of human monoclonal antibodies from Staphylococcus aureus stimulated B lymphocytesM M Gore, S S Singhania, A Basu, et al.Human Antibodies|January 1, 1997
Immunoglobulin A in the epithelium of the respiratory tract and intrahepatic bile ducts of fetuses and newborns with pneumonia and sepsisH Ben-Hur, P Gurevich, M Huszar, et al.Human Antibodies|January 1, 1997
Interferon-alpha neutralizing antibodies in HIV and chronic HCV patients treated with natural-source human leukocyte-derived interferon-alpha n3X X Zhao, J Hua, T Smith, et al.Human Antibodies|January 1, 1997
Class-switching of the IgM type anti-adenocarcinoma human antibody HB4C5 into an IgG1 type resulted in the loss of the antigen binding abilityH Haruta, H Tachibana, K Mochizuki, et al.Human Antibodies|January 1, 1997
Heavy chain variable gene usage by human B-1 lymphocytes and polyreactive autoantibodiesN M Bhat, M M Bieber, N N TengHuman Antibodies|May 18, 2020
A case report of haemolytic disease of the foetus and newborn caused by Alloantibody D and Jka in a Rhesus D negative Nigerian woman: Justification for the implementation of universal access to prophylaxis and evidenced-based best practicesOsaro Erhabor, Williams Bitty Azachi, Erhabor TosanPageof 43